Skip to main content
Premium Trial:

Request an Annual Quote

Chinese Infectious Disease Dx Firm Vision Medicals Raises $14M in Series A Round

NEW YORK – Chinese infectious disease startup Vision Medicals has raised $14 million in a Series A financing round.

The round, which closed last week, was led by Volcanics Venture and CASH Capital.

The company, founded in May 2018 and headquartered in Guangzhou in southern China, has developed a CRISPR-based rapid diagnostics platform for pathogen detection and a metagenomics/metatranscriptomics platform.

It also has a proprietary pathogen nucleic acid enrichment technology (Patho-NET) and microbial databases.

Vision Medicals said it focuses on precision medicine for infectious diseases, including meningitis, encephalitis, respiratory infections, and bloodstream infections.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.